Go back to Resources

Descriptions of benefits and risks in consent forms for Phase 1 oncology trials

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Conjunctiva T-Cell subpopulations in Jorgen’s and non-Jorgen’s patients with dry eye

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT)

Authors:

Location:

Go back to Resources

Go back to Resources

Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials

Authors:

Location:

Go back to Resources

Go back to Resources

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Ability of minority patients to find donors from an ethnically diverse cord blood bank

Authors:

Location:

Go back to Resources

Go back to Resources

4 Year Daclizumab Therapy for Sight Threatening Uveitis

Authors:

Location:

Go back to Resources

Go back to Resources

Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHLBI sponsored trial

Authors:

Location:

Go back to Resources

Go back to Resources

The treatment of JRA-associated uveitis with Etanercept

Authors:

Location:

Go back to Resources